Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹393Cr
Rev Gr TTM
Revenue Growth TTM
27.49%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MANORG
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -16.2 | 4.3 | 9.5 | -14.7 | 0.9 | 8.3 | -18.1 | 12.0 | 42.5 | 24.2 | 14.3 | 32.6 |
| 94 | 100 | 159 | 101 | 95 | 107 | 126 | 108 | 130 | 125 | 158 | 145 |
Operating Profit Operating ProfitCr |
| 9.9 | 8.1 | 5.7 | 9.0 | 9.7 | 9.2 | 8.9 | 12.7 | 13.1 | 14.7 | 0.2 | 11.8 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 17 | 0 |
Interest Expense Interest ExpenseCr | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 6 | 8 | 6 | 7 | 8 |
Depreciation DepreciationCr | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 6 | 6 |
| 2 | 1 | 1 | 1 | 2 | 2 | 3 | 5 | 7 | 15 | 4 | 5 |
| 2 | 0 | 0 | 0 | -1 | 0 | 1 | 1 | 1 | 2 | 1 | 1 |
|
Growth YoY PAT Growth YoY% | -56.8 | 104.5 | 102.9 | 83.7 | 329.8 | 438.7 | 241.3 | 304.4 | 109.8 | 632.3 | 49.3 | 19.0 |
| 0.6 | 0.3 | 0.4 | 0.8 | 2.3 | 1.4 | 1.6 | 2.9 | 3.4 | 8.3 | 2.0 | 2.6 |
| 0.8 | 0.4 | 0.8 | 1.1 | 2.9 | 1.9 | 2.5 | 4.3 | 5.9 | 14.3 | 3.7 | 5.1 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -9.7 | 45.1 | 0.4 | 0.2 | 7.4 | 16.7 |
| 288 | 210 | 400 | 495 | 455 | 471 | 558 |
Operating Profit Operating ProfitCr |
| 23.1 | 37.8 | 18.5 | -0.6 | 7.8 | 11.1 | 9.8 |
Other Income Other IncomeCr | -9 | 1 | 1 | 0 | 1 | 0 | 21 |
Interest Expense Interest ExpenseCr | 5 | 1 | 4 | 14 | 16 | 21 | 28 |
Depreciation DepreciationCr | 9 | 14 | 15 | 18 | 20 | 21 | 23 |
| 63 | 114 | 73 | -34 | 4 | 17 | 31 |
| 15 | 30 | 19 | -7 | 0 | 4 | 6 |
|
| | 76.9 | -36.6 | -150.7 | 115.7 | 193.9 | 97.7 |
| 12.8 | 25.1 | 10.9 | -5.5 | 0.9 | 2.4 | 4.0 |
| 55.5 | 98.8 | 62.7 | -31.6 | 4.9 | 14.6 | 29.0 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| 159 | 243 | 296 | 267 | 272 | 285 | 300 |
Current Liabilities Current LiabilitiesCr | 33 | 54 | 196 | 186 | 181 | 292 | 363 |
Non Current Liabilities Non Current LiabilitiesCr | 14 | 6 | 60 | 44 | 24 | 39 | 58 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 107 | 190 | 344 | 264 | 225 | 317 | 396 |
Non Current Assets Non Current AssetsCr | 108 | 121 | 216 | 242 | 260 | 306 | 334 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 93 | 26 | -84 | 77 | 73 | -8 |
Investing Cash Flow Investing Cash FlowCr | -59 | -28 | -100 | -41 | -40 | -67 |
Financing Cash Flow Financing Cash FlowCr | -36 | 2 | 183 | -36 | -33 | 74 |
|
Free Cash Flow Free Cash FlowCr | 34 | -3 | -184 | 36 | 33 | -75 |
| 194.7 | 31.0 | -156.5 | -282.6 | 1,707.3 | -62.3 |
CFO To EBITDA CFO To EBITDA% | 108.1 | 20.6 | -92.4 | -2,782.8 | 189.3 | -13.4 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 152 | 444 | 770 | 285 | 234 | 305 |
Price To Earnings Price To Earnings | 3.2 | 5.2 | 14.3 | 0.0 | 53.0 | 24.2 |
Price To Sales Price To Sales | 0.4 | 1.3 | 1.6 | 0.6 | 0.5 | 0.6 |
Price To Book Price To Book | 0.9 | 1.8 | 2.5 | 1.0 | 0.8 | 1.0 |
| 2.0 | 3.4 | 10.8 | -171.3 | 10.5 | 9.8 |
Profitability Ratios Profitability Ratios |
| 44.2 | 63.5 | 43.5 | 30.3 | 38.7 | 48.4 |
| 23.1 | 37.8 | 18.5 | -0.6 | 7.8 | 11.1 |
| 12.8 | 25.1 | 10.9 | -5.5 | 0.9 | 2.4 |
| 36.8 | 41.8 | 15.0 | -4.3 | 4.3 | 6.7 |
| 28.6 | 33.7 | 17.7 | -9.9 | 1.5 | 4.3 |
| 22.3 | 27.2 | 9.6 | -5.4 | 0.9 | 2.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Mangalam Organics Limited (MOL), founded in **1946** and headquartered in **Mumbai**, is a leading Indian manufacturer in the **pine chemicals** sector. The company specializes in **terpene and rosin-based chemistry**, producing high-value natural chemicals for industrial and consumer markets. With over **78 years** of operational expertise and a **44-acre manufacturing facility in Kumbhivali, Maharashtra**, MOL has established itself as a global leader—being designated the **world's largest camphor manufacturer in 2022**.
MOL operates under a **single business segment—Chemicals**—and has diversified into **B2B industrial chemicals** and **B2C retail products** through backward integration and forward expansion strategies.
---
### **Strategic Structure & Subsidiary**
- In **April 2020**, MOL established **Mangalam Brands Private Limited (MBPL)**, a **100% wholly owned subsidiary**, to focus exclusively on its **consumer-facing FMCG and retail operations**.
- MBPL was formed via the strategic demerger of **Campure Private Limited** and manages the **Mangalam** and **CamPure** brands.
- As of **FY 2022–23**, **retail operations and associated revenues are reported under MBPL**, resulting in a decline in standalone retail revenue for MOL’s financial statements.
---
### **Core Business Segments (as of 2025)**
MOL operates across three key pillars:
#### **1. B2B Terpene Operations**
- **Primary Product**: **Camphor**, accounting for ~80% of Terpenes segment sales.
- Used in **religious practices**, **healthcare**, **hygiene products**, **pharmaceuticals**, and **aromatherapy** (e.g., Bhimseni Camphor).
- **Other Terpene-Based Products**:
- **Dipentene**: Substitute for limonene, used in paints, detergents, and degreasers; sees strong export demand.
- **Sodium Acetate**: Intermediate in textile dyeing and leather tanning; exported to Europe.
- **Isobornyl Acetate & Isoborneol**: High-margin intermediates for global **flavor & fragrance** industries; currently undergoing customer approvals.
- **Strategy (Aug 2024–Nov 2025)**:
- Expand production of **camphor-based formulations** and **pilot-scale terpene intermediates**.
- Target **global customers** in paint, fragrance, and resin sectors.
- Develop derivatives from **Alpha and Beta Pinene** (e.g., Myrcene, Dihydro Myrcenol) to enter higher-margin fragrance markets.
#### **2. B2B Synthetic Resins**
- **Product Portfolio**:
- **Terpene Phenolic Resin**: Tackifier for adhesives, tyres, rubber, and printing inks.
- **Alkyl Phenolic Resin**: Used in Neoprene/Chloroprene rubber adhesives and tyres.
- **Rosin Esters**: Applied in paints, road markings, and pressure-sensitive adhesives.
- **Strategy (Nov 2025)**:
- Focus on **customized, niche solutions** for industrial clients.
- Expand **terpene phenolic resin range** to meet domestic demand.
- Pursue **product approvals** with global tyre and adhesive manufacturers to expand exports.
- Improve **quality of rosin-modified resins** to **replace imported products** in Indian markets and qualify for exports.
#### **3. B2C Retail Operations (via MBPL)**
- **Branded Portfolio**:
- **Mangalam**: Camphor tablets for **religious use**, positioned as **pure, residue-free, and superior to counterfeit/local brands**.
- **CamPure**: A wellness and home ambience brand offering **camphor soaps, hand washes, vaporisers, air purifiers**, and **home fragrance products**.
- **Private Label Manufacturing**: Supplies to FMCG retailers and modern trade chains.
- **Go-to-Market Strategy (Omni-Channel)**:
- **E-commerce**: Active on **Amazon, Flipkart, Bigbasket, Jiomart**.
- **Modern Trade**: 4,000+ retail stores including Metro, Star Bazaar, and Wellness Forever.
- **General Trade**: Distributed across **18 Indian states**.
- **Export Markets**: USA, UK, Middle East, Africa.
- **Other Channels**: CSD (military), corporate gifting, institutional sales.
- **Retail Expansion (Nov 2025)**:
- **Sales Force**: Expanding to **190 representatives** to strengthen distribution across **14 Indian states**.
- **E-commerce Reach**: Grew from 12,000 pin codes (FY23) to **21,000+ pin codes (FY24)**, with plans for further expansion.
- **Marketing**: Investing in **digital marketing**, **TV commercials**, exhibitions, and sampling to drive brand awareness.
---
### **Manufacturing & Operations**
- **Facility**: 44-acre **automated plant in Kumbhivali, Raigad, Maharashtra**, near **Mumbai-Pune Expressway** and **60 km from JNPT Port**.
- **Capabilities**:
- Backward-integrated, relying on **natural raw materials** (turpentine) sourced globally from **Brazil, Argentina, USA, Russia, China, and Southeast Asia**.
- Complies with **pollution control norms**, using **effluent treatment**, **energy-efficient equipment**, and **Lean Six Sigma** practices.
- **Capacity Expansion**:
- **Camphor**: 10,000 MT/year (as of 2022–23).
- **Bhimseni/Isoborneol Flakes**: 2,500 MT/year (achieved in 2025).
- Ongoing capacity upgrades to support new grades and meet rising domestic/export demand.
---
### **Global Presence & Export Strategy**
- MOL supplies to **Europe, USA, Africa, Middle East, Southeast Asia, and Asia Pacific**.
- **Export Growth (Nov 2025)**:
- Entered **USA and UK consumer markets** through MBPL.
- Growing export demand for **Dipentene** (due to limonene shortages) and **Sodium Acetate**.
- Targeting **product approvals** with **global tyre and adhesive manufacturers** to expand resin exports.
---
### **Key Milestones & Timeline**
| **Year** | **Key Development** |
|--------|---------------------|
| **1946** | Founded by Late Ramgopal Dujodwala (rosin trading). |
| **1949** | Rosin & turpentine manufacturing units in North India. |
| **1988** | Rosin/turpentine facility in Khopoli, Maharashtra. |
| **1994** | Camphor plant established; listed on **BSE**; public issue of ₹8.7 crore. |
| **2007** | Kamal Dujodwala becomes Chairman; launches **Synthetic Resins division**. |
| **2013** | Launches **Mangalam Camphor Tablets** (B2C). |
| **2017** | Launches **CamPure** homecare brand. |
| **2020** | Forms **Mangalam Brands Private Limited (MBPL)**. |
| **2021** | Listed on **NSE**. |
| **2022** | Reaches **10,000 MT camphor capacity**; becomes **global leader in camphor**. |
| **2025** | Expands **Isoborneol capacity**; strengthens **e-commerce**, **export**, and **retail distribution**. |
---
### **Positioning & Vision (2025)**
MOL is transitioning from a commoditized **industrial chemical supplier** to an **integrated specialty chemicals and FMCG player**:
- **B2B**: Focus on **niches, customization, and eco-friendly alternatives** in synthetic resins.
- **B2C**: Building **branded, wellness-driven consumer products** under **Mangalam and CamPure** with a strong **omni-channel retail strategy**.
- **Sustainability & Innovation**: Natural, pine-based chemistry insulates from crude oil volatility and aligns with global sustainability trends.
---